Press Releases

Pion Inc. Acquires Sirius Analytical Instruments Ltd.
May 25, 2017

Pion Inc. announced today the acquisition of Sirius Analytical Instruments Ltd., headquartered in East Sussex, United Kingdom. Building off the 2016 acquisition of Vortex’s laboratory equipment services division, acquiring Sirius continues Pion’s initiative to grow their global footprint in instrumentation and services. Now with key facilities in both North America and Europe, Pion can provide faster and more efficient support to all customers and distributors.

 

Pion Inc. launches the NEW MacroFLUX technology at AAPS
December 12, 2016

Participants at AAPS were able to see the newest addition to the FLUX family of products. Building on the success and effectiveness of Pion’s PAMPA and µFLUX, Pion continues to invest in and develop solutions for biorelevent data.

 

New FLUX technology from Pion adds real-time, IVIVC absorption prediction to dissolution testing
October 18, 2016

Pharmaceutical scientists have long sought a reliable method for predicting the absorption potential of finished dosage products prior to clinical trials, but have been frustrated by the limitations of standard dissolution testing, which cannot predict the in vivo response to drug products due to the complex interplay of solubility and permeability in the human body. Now, for the first time, new FLUX testing technology from Pion combines traditional dissolution testing with a repeatable method for assessing the absorption potential of APIs, API/ingredient combinations, or finished dosage products. The result is a single combined test that makes more reliable and realistic IVIVC (in vitro-in vivo correlation) testing and modeling possible.

 

Pion Inc. welcomes new Senior Service Engineer and International Sales Manager
April 15, 2016

Pion strengthens its presence in the pharmaceutical industry by increasing headcount to cover growing needs in U.S. and EMEIA

 

Pion Inc. Acquires the Service Business of Vortex Sales Group
April 6, 2016

Pion strengthens its brand in the pharmaceutical industry by increasing its range of service offerings and support personnel across the USA

 

Konstantin Tsinman promoted to Chief Scientific Officer
March 2, 2016

Pion Inc. continues to strengthen position in pharmaceutical R&D with the on-going professional advancement of this leader in the global drug-development industry

 

Pion to Exhibit 11 Posters at 2015 AAPS
October 8, 2015

Pion collaborated with top researchers from Novartis, Nanocopoeia and Leading Universities on Posters for 2015 AAPS.

 

Pion and BASF Collaborate on Drug Development & Delivery Publication
January 15, 2015

Pion Inc. has joined forces with Dr. Shaukat Ali from BASF to develop a new protocol for testing drug supersaturation. 

 

Au PRO
June 12, 2014

Pion launches the latest and revoulutionary in situ concentration monitoring software the Au PRO

 

µDISS ProfilerPLUS™ and Miniaturized Dissolution
February 25, 2014

 

Pion Launches the µFLUX™ - A Novel Dissolution–Permeability Apparatus
January 14, 2014

 

Pion Launches the Latest Version of Indigo Software 4.0
March 13, 2013

 

Considerable improvements were made to the MiniBath module of the µDISS ProfilerPLUS™ including *8* individual sample stations and computer controlled stirring.
March 13, 2013

 

µDISS ProfilerPLUS™ and Miniaturized Dissolution
March 13, 2013

 

Gemini Profiler™ Electrode Upgrade
March 8, 2013